exhibit 10. 2 sarepta therapeutics, inc. amended and restated 2013 employee stock purchase plan ( as amended and restated on june 27, 2016 ) sarepta therapeutics, inc., a delaware corporation ( the “ company ” ), hereby adopts the sarepta therapeutics, inc. amended and restated 2013 employee stock purchase plan ( the “ plan ” ), effective as of the effective date ( as defined herein ). 1. purpose. the purposes of the plan are as follows : ( a ). to encourage eligible employees of the company and its designated subsidiaries ( as defined below ) to acquire stock ownership interests in the company pursuant to a plan which is intended to qualify as an “ employee stock purchase plan ” within the meaning of section 423 ( b ) of the internal revenue code of 1986, as amended. ( b ). to help eligible employees provide for their future financial security and to encourage such employees to remain in the employment of the company and its designated subsidiaries. 2. definitions. ( a ). “ administrator ” shall mean the administrator of the plan, as determined pursuant to section 14 hereof. ( b ). “ adoption date ” shall mean june 27, 2016, which is the effective date adopted by the board, subject to its approval by stockholders of the company in accordance with the company ’ s bylaws, articles of incorporation and applicable state law within twelve months of the date the plan is adopted by the board. ( c ). “ board ” shall mean the board of directors of the company. ( d ). “ code ” shall mean the internal revenue code of 1986, as amended. ( e ). “ committee ” shall mean the committee appointed to administer the plan pursuant to section 14 hereof. ( f ). “ common stock ” shall mean the common stock of the company. “ common stock ” shall also include ( i ) the common stock of the surviving corporation in any consolidation, merger or reincorporation effected exclusively to change the domicile of the company and ( ii ) such other securities of the company that may be substituted for common stock pursuant to section 17 hereof. ( g ). “ company ” shall mean sarepta therapeutics, inc., a delaware corporation, or any successor corporation ( including, without limitation, the surviving corporation in any consolidation, merger or reincorporation effected exclusively to change the domicile of the company ). ( h